V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007904 | 220003154 | null | 96.6 | Curative (C) | 2014-02-08 | 2014-02-08 | Cytarabine High Dose | 01 | N | 220033398 | CYTARABINE HIGH DOSE |
| 220007905 | 220003154 | 1.56 | 74.3 | Curative (C) | 2014-07-30 | 2014-07-30 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220033398 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220007906 | 220003154 | 1.7 | 94.2 | Palliative (P) | 2013-12-18 | 2013-12-19 | Carboplatin + Etoposide iv&po | 2 | N | 220033398 | CARBOPLATIN + ETOPOSIDE |
| 220007907 | 220003154 | null | 78.2 | Palliative (P) | 2013-07-28 | 2013-08-11 | Capecitabine + Oxaliplatin 21day | 02 | N | 220033398 | CAPECITABINE + OXALIPLATIN |
| 220007908 | 220003154 | 1.64 | 88 | Palliative (P) | 2013-12-21 | 2013-12-25 | RAVVA TRIAL | N | N | 220033398 | GEMCITABINE |
| 220007909 | 220003155 | 1.72 | 69.2 | Palliative (P) | 2013-03-06 | 2013-05-04 | Carboplatin AUC 2 - 5 | N | null | 220033410 | CARBOPLATIN |
| 220007910 | 220003155 | 1.65 | 56.4 | Adjuvant (A) | 2017-11-07 | 2017-11-12 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220033410 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220007911 | 220003156 | 1.73 | 93.8 | Palliative (P) | 2017-04-05 | 2017-04-05 | ECX | N | null | 220033416 | ECX |
| 220007912 | 220003157 | 1.61 | 86.7 | Palliative (P) | 2017-06-21 | 2017-06-24 | CARBOPLATIN + ETOPOSIDE | Y | N | 220033417 | CARBOPLATIN + ETOPOSIDE |
| 220007913 | 220003158 | null | 108.8 | Curative (C) | 2015-06-16 | 2015-06-16 | ADE 10+3+5 | N | N | 220033419 | ADE |
| 220007914 | 220003159 | 1.56 | 79.6 | Curative (C) | 2017-08-12 | 2017-08-13 | ADE 10+3+5 | 02 | null | 220033420 | ADE |
| 220007915 | 220003159 | 1.7 | null | Palliative (P) | 2017-07-26 | 2017-08-10 | Capecitabine + Oxaliplatin 21day | 02 | N | 220033420 | CAPECITABINE + OXALIPLATIN |
| 220007916 | 220003159 | null | 71.8 | Curative (C) | 2014-05-25 | 2014-05-25 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 220033420 | PEMBROLIZUMAB |
| 220007917 | 220003159 | 1.73 | 72 | Palliative (P) | null | 2013-03-10 | Carboplatin + Etoposide iv&po | 02 | N | 220033420 | CARBOPLATIN + ETOPOSIDE |
| 220007918 | 220003159 | 1.81 | 76.8 | Disease modification (D) | 2015-03-31 | 2015-04-11 | RAVVA TRIAL | null | N | 220033420 | GEMCITABINE |
| 220007919 | 220003159 | null | 88.3 | Curative (C) | 2014-06-12 | 2014-07-13 | CARBOPLATIN | N | null | 220033420 | CARBOPLATIN |
| 220007920 | 220003160 | 1.7 | 72.3 | Palliative (P) | 2013-05-30 | 2013-06-19 | EOX | 02 | N | 220033433 | EOX |
| 220007925 | 220020449 | 1.66 | 0 | Palliative (P) | 2013-11-20 | 2013-11-20 | EOX | Y | N | 220033441 | EOX |
| 220007926 | 220020449 | 1.65 | 66 | Not known (9) | 2013-12-25 | 2014-01-10 | EOX | 02 | N | 220033441 | EOX |
| 220007927 | 220020449 | 0 | 66.35 | Palliative (P) | 2014-12-20 | 2014-12-23 | Carboplatin + Etoposide iv&po | 1 | N | 220033441 | CARBOPLATIN + ETOPOSIDE |
| 220007928 | 220020449 | 1.72 | 51.6 | Curative (C) | 2015-08-13 | 2015-08-13 | FLAG | N | N | 220033441 | FLAG |
| 220007929 | 220003162 | 1.78 | 81.1 | null | 2017-01-10 | 2017-01-10 | Carboplatin + Etoposide iv&po | N | N | 220033448 | CARBOPLATIN + ETOPOSIDE |
| 220007930 | 220003163 | 1.65 | 89 | Disease modification (D) | 2017-11-03 | 2017-11-03 | Rituximab | 02 | N | 220033449 | PEMBROLIZUMAB |
| 220007931 | 220003164 | 1.6 | 90.2 | null | 2013-10-06 | 2013-10-06 | EOX | 02 | N | 220033450 | EOX |
| 220007932 | 220003164 | null | null | Palliative (P) | 2017-09-25 | 2017-09-25 | Oxaliplatin + Modified de Gramont | N | null | 220033450 | OXALIPLATIN + MDG |
| 220007933 | 220003165 | 1.78 | 67 | Palliative (P) | 2015-01-17 | 2015-01-31 | EOX | N | N | 220033452 | EOX |
| 220007934 | 220003165 | 1.8 | 92 | null | 2013-11-11 | 2013-11-16 | FLAG | N | N | 220033452 | FLAG |
| 220007935 | 220003165 | 1.52 | 65.25 | Palliative (P) | 2014-11-02 | 2014-11-02 | CAPECITABINE + OXALIPLATIN | 02 | null | 220033452 | CAPECITABINE + OXALIPLATIN |
| 220007936 | 220003165 | 1.7 | 66.8 | Curative (C) | 2016-09-25 | 2016-09-29 | AML Int Guide ADE 10+3+5 (1) | 01 | null | 220033452 | ADE |
| 220007937 | 220003165 | 1.61 | 54.4 | Palliative (P) | null | 2014-02-03 | ECX | 2 | N | 220033452 | ECX |
| 220007938 | 220003165 | 1.66 | 95 | Palliative (P) | 2014-04-26 | 2014-04-29 | ECX | Y | N | 220033452 | ECX |
| 220007939 | 220003165 | 1.58 | 77.7 | Palliative (P) | 2017-12-25 | 2017-12-30 | Carboplatin + Etoposide iv&po | null | null | 220033452 | CARBOPLATIN + ETOPOSIDE |
| 220007940 | 220003165 | 0 | 87 | Palliative (P) | 2015-07-10 | 2015-07-11 | RAVVA TRIAL | N | null | 220033452 | PEMBROLIZUMAB |
| 220007941 | 220003165 | 1.81 | 130.6 | Not known (9) | 2015-07-30 | 2015-08-03 | ECX | N | N | 220033452 | ECX |
| 220007942 | 220003166 | 1.56 | 119.2 | Not known (9) | 2013-02-25 | 2013-03-11 | EOX | 2 | N | 220033480 | EOX |
| 220007943 | 220003166 | null | 55 | Palliative (P) | 2017-06-16 | 2017-06-17 | Capecitabine + Oxaliplatin 14day | 02 | N | 220033480 | CAPECITABINE + OXALIPLATIN |
| 220007944 | 220003167 | 1.63 | 61.8 | Adjuvant (A) | null | 2017-01-05 | FLAG | 2 | N | 220033484 | FLAG |
| 220007945 | 220003168 | 1.57 | 92 | null | null | 2013-12-18 | Cisplatin + Radiotherapy | 02 | N | 220033485 | CISPLATIN + RT |
| 220007946 | 220003169 | null | 67.2 | Curative (C) | 2018-01-08 | 2018-01-09 | FLAG | 02 | N | 220033488 | FLAG |
| 220007947 | 220003169 | 1.66 | 64.7 | Curative (C) | 2013-08-28 | 2013-08-28 | ADE | N | N | 220033488 | ADE |
| 220007948 | 220003169 | 1.76 | 107 | null | 2015-11-10 | 2015-11-17 | ECX | 01 | N | 220033488 | ECX |
| 220007949 | 220003170 | 1.74 | null | null | 2017-02-02 | 2017-02-02 | ECX | 02 | N | 220033493 | ECX |
| 220007950 | 220003171 | 1.72 | 109.6 | Palliative (P) | 2013-05-06 | 2013-05-07 | EOX | 02 | Y | 220033496 | EOX |
| 220007951 | 220003171 | 1.65 | 53.7 | Palliative (P) | 2014-06-22 | 2014-06-26 | EOX | N | N | 220033496 | EOX |
| 220007952 | 220003171 | null | null | Palliative (P) | 2016-02-29 | 2016-03-10 | RAVVA TRIAL | 02 | N | 220033496 | GEMCITABINE |
| 220007953 | 220003171 | null | 78.4 | Curative (C) | 2014-09-08 | 2014-09-09 | Cytarabine High Dose | N | N | 220033496 | CYTARABINE HIGH DOSE |
| 220007954 | 220003171 | 1.65 | null | Palliative (P) | null | 2015-11-16 | Carboplatin + Etoposide IV 3 day | N | N | 220033496 | CARBOPLATIN + ETOPOSIDE |
| 220007955 | 220003171 | 1.65 | 57 | Curative (C) | 2016-09-26 | 2016-09-27 | AML Int Guide ADE 10+3+5 (1) | N | N | 220033496 | ADE |
| 220007956 | 220021764 | 1.79 | 121.7 | Curative (C) | 2015-05-27 | 2015-05-27 | Alemtuz+Fludara+Melphalan RIC MUD | 1 | N | 220033511 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220007957 | 220021764 | 1.76 | null | Palliative (P) | 2017-08-08 | 2017-08-08 | CARBOPLATIN + ETOPOSIDE | N | N | 220033511 | CARBOPLATIN + ETOPOSIDE |